Aasld News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aasld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aasld Today - Breaking & Trending Today

From NAFLD to MASLD: 2023 Brings New Liver Disease Nomenclature

Following years of concerns about the stigmatization and inaccurate etiology of nonalcoholic fatty liver disease nomenclature, 2023 finally saw revised terminology for liver disease with the implementation of metabolic dysfunction-associated steatotic liver disease. ....

United States , Mazen Noureddin , Jamile Wakim Fleming , Thomas Addison , Mark Sulkowski , Anthony Martinez , Erie County Medical Center , Johns Hopkins University , American Liver Foundation , Houston Research Institute , Nomenclature Development Initiative , Schulich School Of Medicine At Western University , American Association , Liver Disease , European Association , Latin American Association , Metabolic Steatosis , Cleveland Clinic , Asian Pacific Association , Pablo Arab , Schulich School , Western University , Accessed December , Nonalcoholic Fatty Liver , Intj Mol , Consensus Driven Proposed Nomenclature ,

Guillaume Lassailly: How Do We Value Bariatric Surgery in 2023?

Lassailly discusses the role of bariatric surgery versus weight-loss treatments like semaglutide for patients with MASH. ....

United States , Guillaume Lassailly , Centre Hospitalier Universitaire De Lille , Liver Meeting , American Association , Liver Diseases , Weight Loss ,

Ricky Safer: What Clinicians Need to Know About PSC

Safer discusses how symptoms and quality of life often go unaddressed in the few clinician-patient interactions about primary sclerosing cholangitis. ....

United States , Liver Meeting , American Association , Liver Diseases , Ricky Safer , Primary Sclerosing Cholangitis , Psc Parners Seekinga Cure ,

Arun Sanyal, MD: Retatrutide and GLP-1 Agonists in MASLD

Sanyal discusses the makeup of retatrutide and its potential for patients with fatty liver disease and comorbid metabolic conditions. ....

United States , Arunj Sanyal , Liver Meeting , American Association , Liver Diseases , Glp 1 , Fatty Liver ,

Serum Bile Acid Independently Predicts Liver Survival in Alagille Syndrome with Neonatal Cholestasis

A new study from the GALA cohort shows serum bile acid's association with clinical outcomes is relevant in the context of IBAT inhibitor therapy. ....

United States , C Fiorella Murillo Perez , Study Group , Global Alagille Alliance , Murillo Perez , Cymabay Therapeutics , Liver Meeting , American Association , Liver Diseases , Alagille Syndrome , Bile Acid , Risk Factor , Liver Transplant , Gala Study ,